WhitmanTrading

Growth Investing vs Factor Investing

Growth investing buys companies expanding quickly, on the expectation that expansion continues. Factor investing applies characteristics with documented long-run records — value, size, momentum, quality, low volatility — as systematic rules, and rapid growth on its own is not among the well-supported ones.

Growth is listed alongside value as though the two were symmetrical opposites with equal standing. They are not. Value has a long documented record and growth, as a standalone characteristic, mostly does not — which makes this comparison more one-sided than the framing suggests.

What each one is

Growth investing buys companies expanding quickly, expecting the expansion to continue and to justify a high price. Growth investing covers it.

Factor investing applies documented characteristics as systematic rules across a large universe. Factor investing covers which ones, and value investing covers the best-known of them.

One is a characteristic with a record and the other is mostly a story. Whereas value, momentum, quality and size have long-run evidence behind them, rapid revenue growth on its own has been a much weaker predictor — and where growth investing works, it usually turns out to be about profitability rather than about expansion.

Where they differ

A steeply rising series representing rapid expansion.
Fast growth: usually already reflected in the price. Illustrative chart - not real market data.

Whether the characteristic is already priced. This is the core problem with growth. A company everybody can see is expanding trades at a price reflecting that, so buying it is not buying a mispricing — it is buying a consensus and hoping the consensus was too conservative.

A broad rising series representing many holdings selected by rule.
A documented characteristic, applied by rule across hundreds. Illustrative chart - not real market data.

How many companies are involved. Growth investing tends to concentrate on a handful of well-known names with compelling narratives. Factor investing holds hundreds, relying on the average rather than on any individual story.

A stretch where a concentrated growth holding and a broad tilt separate.
Where a narrative and a rule give different answers. Illustrative chart - not real market data.

What the evidence actually supports. Where systematic research finds an effect in this territory it is generally profitability or quality — companies that already earn well and reinvest at good rates — rather than companies whose revenue is rising fastest. Those overlap and are not the same screen.

How the failure arrives. Growth investing fails when expansion slows and the price falls a long way because it was priced for continuation. Factor investing fails by lagging for years, which is slower and much less dramatic.

Where they agree

A long rising series with a shaded drawdown region.
Both are equity bets and both sit through declines. Illustrative chart - not real market data.

Both are departures from market weights, and both therefore need a reason and a holding period.

Both require long horizons. On this site’s shared series 95% of bars sat below a prior peak, with the longest wait for a new high at 73 bars.

Both are eaten by costs — over thirty years, 75 basis points removes 20.2% of a pot, and both growth funds and factor funds usually charge more than a plain tracker.

And both are undermined by switching after poor performance, which is the reliable way to do badly with either.

Which one to use

A series showing the compounding effect of an annual charge.
What a 75-basis-point charge removes over thirty years. Illustrative chart - not real market data.

Use factors when you want characteristics with a record. Value, momentum and quality have been studied over long periods across many markets, and a systematic tilt toward them is a defensible position you can state a reason for.

A steeply rising series with a marked company-specific event.
Where a specific view about a specific company is the edge. Illustrative chart - not real market data.

Use growth investing when you have a genuine view the market lacks. That is a high bar and it is the only honest version — buying a fast-growing company because it is fast-growing is buying what everyone can already see.

Prefer quality when you are drawn to growth. If the appeal is well-run businesses that compound, the characteristic with the evidence is profitability rather than revenue expansion.

And hold several factors rather than one, since a single-factor position is one bet with a rules wrapper.

Why “already priced” is the whole objection

A series annotated with the drag from an annual charge.
Costs apply throughout, whichever characteristic you tilt toward. Illustrative chart - not real market data.

Because a visible characteristic cannot be an edge on its own. Everybody can see which companies are growing; the price already reflects it. An effect only persists if there is a reason people systematically underpay for it, and the argument for that is much stronger for cheapness and for profitability than for expansion.

A section of a series showing a sharp decline after a peak.
A company priced for continuation falls furthest when it slows. Illustrative chart - not real market data.

And because a price built on continuation is fragile. When expansion slows, the fall reflects both the lower growth and the lower multiple people will pay for it, which is why disappointments in this space are so large.

The original data

Of the 24,971 videos in the search corpus, no title compares these two directly. Growth investing appears in 19 videos at a median of 573 views across 18 channels — the lowest median of any investing subject measured here. Factor investing appears in 3 videos at a median of 50,285 across 3 channels.

A series with several discontinuities, the largest marked.
A growth disappointment arrives as a single large gap. Illustrative chart - not real market data.

573 against 50,285 — a ratio of nearly ninety to one. The characteristic with the least support draws almost no audience despite more coverage, and the systematic approach with a documented record has three videos and one of the largest audiences per item in the corpus.

A rising series cut short at a decision point.
The company is growing fast and everybody knows. Is that an edge? Illustrative chart - not real market data.

On the chart above visible growth is not an edge by itself. The price already contains it, and the question is only whether it contains too little.

When it fails

The characteristic failure is treating growth as a factor and expecting a factor’s behaviour. Someone who has read that factors deliver over long horizons applies that patience to a portfolio of fast-growing companies, holds through a severe drawdown, and waits for the reversion that the factor literature promised — except that the promise was made about value, momentum, quality and size, not about revenue expansion. The discipline is admirable and it is being applied to a characteristic that was never shown to reward it, so the holding period does not rescue the position the way it would have rescued a genuine tilt.

A second failure is buying growth companies because they have risen, which is momentum with a different label and should be recognised as such.

A third is holding one factor and calling it diversified, when it is a single bet.

A fourth is paying active-level fees for a rules-based product, which removes its cost advantage.

And a fifth is judging any of this on three years, which is far too short to separate an effect from chance.

Growth investing covers buying expansion and what it costs. Factor investing covers the characteristics with long-run records. And value investing covers the best-documented of them.

What I actually do

Growth is the characteristic everybody assumes is an edge and it is the one with the thinnest support. The version that holds up is profitability — companies that already earn well, rather than companies expected to earn well later — and the difference between those two is the whole subject.

— Michael Whitman

This page is educational, not financial advice. Test every idea on your own charts before risking money.